BRIEF: Cloudbreak tumbles in Hong Kong trading debut

Ophthalmic biotech company Cloudbreak Pharma Inc. (2592.HK) opened down 6% in its Hong Kong trading debut on Wednesday, and continued to fall during the morning session to close down 30% at HK$7.04…

BRIEF: Cloudbreak launches $78 million Hong Kong IPO

Ophthalmic biotech company Cloudbreak Pharma Inc. (2592.HK) launched its Hong Kong IPO on Tuesday, aiming to sell 60.58 million shares at HK$10.10 apiece to raise about HK$610 million ($78 million). Share…
Bayzed does healthcare

BRIEF: Bayzed Health jumps in Hong Kong trading debut

Shares of cancer hospital operator Bayzed Health Group Inc. (2609.HK) jumped in their Hong Kong trading debut on Monday, as the company raised HK$562 million ($72 million) in an IPO that received…
Bayzed does healthcare

BRIEF: BrainAurora CEO resigns, citing health reasons

BrainAurora Medical Tech Ltd. (6681.HK) announced on Friday that its CEO and chief research officer Wang Xiaoyi resigned, effective Thursday, due to health issues caused by worsening depression. The company…
Bayzed does healthcare

BRIEF: Hengrui executive to sell nearly 500,000 A-shares

Pharmaceutical company Jiangsu Hengrui Pharmaceuticals Co. Ltd. (1276.HK; 600276.SH) said on Sunday that executive director and senior vice president Sun Jieping will sell up to 476,700 of his A-shares in…